Comparison of Mitoxantrone and Ametantrone in Human Acute Myelocytic Leukemia Cells in Culture and in Bone Marrow Granulocyte-Macrophage Progenitor Cells

George Fountzilas; Takao Ohnuma; Kiriakos Rammos; Bruce Mindich; James F. Holland

doi:10.1089/cdd.1986.3.93

Comparison of Mitoxantrone and Ametantrone in Human Acute Myelocytic Leukemia Cells in Culture and in Bone Marrow Granulocyte-Macrophage Progenitor Cells

George Fountzilas, Takao Ohnuma, Kiriakos Rammos, Bruce Mindich, James F. Holland

Icahn School of Medicine at Mount Sinai

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Abstract

The cytocidal effects of mitoxantrone and ametantrone were compared in 3 human acute myelocytic leukemia (AML) cell lines by means of clonogenic as well as cell growth inhibition assay. The effects of these two agents were also compared on normal bone marrow granulocyte-macrophage progenitor cells (CFU-GM). Mitoxantrone was 10– fold more potent against AML cells than ametantrone. Longer exposure of cells to these agents resulted in increased cell kill, but with lesser efficiency. Both mitoxantrone and ametantrone were more cytocidal on normal bone marrow CFU-GM than on AML cells; mitoxantrone was approximately 2.5-fold and ametantrone nearly 10-fold more active against CFU-GM than against HL-60 AML cells.

Original language	English
Pages (from-to)	93-100
Number of pages	8
Journal	Cancer Drug Delivery
Volume	3
Issue number	2
DOIs	https://doi.org/10.1089/cdd.1986.3.93
State	Published - 1986

Access to Document

10.1089/cdd.1986.3.93

Cite this

@article{97276f9d9ad047b28bba53fc5355fd2c,

title = "Comparison of Mitoxantrone and Ametantrone in Human Acute Myelocytic Leukemia Cells in Culture and in Bone Marrow Granulocyte-Macrophage Progenitor Cells",

abstract = "The cytocidal effects of mitoxantrone and ametantrone were compared in 3 human acute myelocytic leukemia (AML) cell lines by means of clonogenic as well as cell growth inhibition assay. The effects of these two agents were also compared on normal bone marrow granulocyte-macrophage progenitor cells (CFU-GM). Mitoxantrone was 10– fold more potent against AML cells than ametantrone. Longer exposure of cells to these agents resulted in increased cell kill, but with lesser efficiency. Both mitoxantrone and ametantrone were more cytocidal on normal bone marrow CFU-GM than on AML cells; mitoxantrone was approximately 2.5-fold and ametantrone nearly 10-fold more active against CFU-GM than against HL-60 AML cells.",

author = "George Fountzilas and Takao Ohnuma and Kiriakos Rammos and Bruce Mindich and Holland, {James F.}",

year = "1986",

doi = "10.1089/cdd.1986.3.93",

language = "English",

volume = "3",

pages = "93--100",

journal = "Cancer Drug Delivery",

issn = "0732-9482",

publisher = "Mary Ann Liebert Inc.",

number = "2",

}

TY - JOUR

T1 - Comparison of Mitoxantrone and Ametantrone in Human Acute Myelocytic Leukemia Cells in Culture and in Bone Marrow Granulocyte-Macrophage Progenitor Cells

AU - Fountzilas, George

AU - Ohnuma, Takao

AU - Rammos, Kiriakos

AU - Mindich, Bruce

AU - Holland, James F.

PY - 1986

Y1 - 1986

N2 - The cytocidal effects of mitoxantrone and ametantrone were compared in 3 human acute myelocytic leukemia (AML) cell lines by means of clonogenic as well as cell growth inhibition assay. The effects of these two agents were also compared on normal bone marrow granulocyte-macrophage progenitor cells (CFU-GM). Mitoxantrone was 10– fold more potent against AML cells than ametantrone. Longer exposure of cells to these agents resulted in increased cell kill, but with lesser efficiency. Both mitoxantrone and ametantrone were more cytocidal on normal bone marrow CFU-GM than on AML cells; mitoxantrone was approximately 2.5-fold and ametantrone nearly 10-fold more active against CFU-GM than against HL-60 AML cells.

AB - The cytocidal effects of mitoxantrone and ametantrone were compared in 3 human acute myelocytic leukemia (AML) cell lines by means of clonogenic as well as cell growth inhibition assay. The effects of these two agents were also compared on normal bone marrow granulocyte-macrophage progenitor cells (CFU-GM). Mitoxantrone was 10– fold more potent against AML cells than ametantrone. Longer exposure of cells to these agents resulted in increased cell kill, but with lesser efficiency. Both mitoxantrone and ametantrone were more cytocidal on normal bone marrow CFU-GM than on AML cells; mitoxantrone was approximately 2.5-fold and ametantrone nearly 10-fold more active against CFU-GM than against HL-60 AML cells.

UR - http://www.scopus.com/inward/record.url?scp=0022492174&partnerID=8YFLogxK

U2 - 10.1089/cdd.1986.3.93

DO - 10.1089/cdd.1986.3.93

M3 - Article

C2 - 3458518

AN - SCOPUS:0022492174

SN - 0732-9482

VL - 3

SP - 93

EP - 100

JO - Cancer Drug Delivery

JF - Cancer Drug Delivery

IS - 2

ER -

Comparison of Mitoxantrone and Ametantrone in Human Acute Myelocytic Leukemia Cells in Culture and in Bone Marrow Granulocyte-Macrophage Progenitor Cells

Abstract

Access to Document

Fingerprint

Cite this